Form D · Manufacturing
Lincoln Park Biosciences, LLC
Scottsdale, AZ · CIK 0001932382
Offering snapshot reported Jun 23, 2022 · SEC filing
- Reported sold
- $400K Offering amount: $400K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Jun 20, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2022 | Initial | $400,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-449991
Source: Form D, filed Jun 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marcus Mamolen | Executive |
| Jonathan Tessmar Bell | Executive |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
6835 E. Camelback Rd. #8015
Scottsdale, AZ, 85251
Scottsdale, AZ, 85251